Key points
- Revenues down 21.3% to $6,083,034
- Loss from ordinary activities up 451.4% to $(398,121)
- Sold Embedded Health Solutions for $5m
- No dividends declared or paid
- Audit report expected to contain an unqualified opinion with going concern note
Full summary
Careteq Ltd reported a preliminary final report for the year ended 30 June 2026. The company experienced a 21.3% drop in revenues to $6,083,034 and a substantial loss increase of 451.4% to $(398,121). No dividends were declared or paid during the financial year. Careteq completed the sale of its subsidiary, Embedded Health Solutions, for $5 million, utilizing the proceeds to settle vendor loans. The financial statements are currently under audit, with an expected unqualified opinion including a going concern note.
Guidance
Revenues down 21.3%, loss from ordinary activities up 451.4% to $(398,121) for FY2026
Outlook
Careteq plans to focus on growth of its marketplace platform HMR Referrals, leveraging the net proceeds from the sale of Embedded Health Solutions.